Home › Compare › GFTRF vs JNJ

GFTRF vs JNJ: Dividend Comparison 2026

GFTRF yields 20000.00% · JNJ yields 3.36%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 GFTRF wins by $52481917574412746752.00M in total portfolio value
10 years
GFTRF
GFTRF
● Live price
20000.00%
Share price
$0.01
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$52481917574412746752.00M
Annual income
$51,970,745,957,167,775,000,000,000.00
Full GFTRF calculator →
JNJ
Johnson & Johnson
● Live price
3.36%
Share price
$147.50
Annual div
$4.96
5Y div CAGR
5.8%
Payout ratio
55%
After 10 yrs · $10,000 · DRIP
Portfolio value
$20.0K
Annual income
$827.78
Full JNJ calculator →

Portfolio growth — GFTRF vs JNJ

📍 GFTRF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodGFTRFJNJ
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, GFTRF + JNJ cover 0 of 12 months — good coverage

Jan
—
Feb
—
Mar
—
Apr
—
May
—
Jun
—
Jul
—
Aug
—
Sep
—
Oct
—
Nov
—
Dec
—
GFTRF pays
JNJ pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

GFTRF
Annual income on $10K today (after 15% tax)
$1,700,000.00/yr
After 10yr DRIP, annual income (after tax)
$44,175,134,063,592,610,000,000,000.00/yr
JNJ
Annual income on $10K today (after 15% tax)
$285.83/yr
After 10yr DRIP, annual income (after tax)
$703.61/yr
At 15% tax rate, GFTRF beats the other by $44,175,134,063,592,610,000,000,000.00/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of GFTRF + JNJ for your $10,000?

GFTRF: 50%JNJ: 50%
100% JNJ50/50100% GFTRF
Portfolio after 10yr
$26240958787206373376.00M
Annual income
$25,985,372,978,583,888,000,000,000.00/yr
Blended yield
99.03%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on JNJ right now

GFTRF
No analyst data
Altman Z
-832.5
Piotroski
2/9
JNJ
Analyst Ratings
20
Buy
17
Hold
3
Sell
Consensus: Buy
Price Target
$228.73
+55.1% upside vs current
Range: $190.00 — $265.00
Altman Z
5.2
Piotroski
4/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

GFTRF buys
0
JNJ buys
0
No recent congressional trades found for GFTRF or JNJ in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricGFTRFJNJ
Forward yield20000.00% ✓3.36%
Annual dividend / share$2.00$4.96 ✓
Payout ratio50% ✓55%
1-year div growth0%4.2% ✓
5-year div CAGR0%5.8% ✓
Portfolio after 10y$52481917574412746752.00M ✓$20.0K
Annual income after 10y$51,970,745,957,167,775,000,000,000.00 ✓$827.78
Total dividends collected$52448189483771600896.00M ✓$5.6K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: GFTRF vs JNJ ($10,000, DRIP)

YearGFTRF PortfolioGFTRF Income/yrJNJ PortfolioJNJ Income/yrGap
1← crossover$2,010,700$2,000,000.00$10,676$355.77+$2.00M → GFTRF
2$377,983,225$375,831,775.70$11,407$389.39+$377.97M → GFTRF
3$66,433,479,469$66,029,037,418.28$12,198$426.53+$66433.47M → GFTRF
4$10,916,985,471,987$10,845,901,648,955.73$13,056$467.62+$10916985.46M → GFTRF
5$1,677,384,363,769,318$1,665,703,189,314,291.80$13,987$513.12+$1677384363.76M → GFTRF
6$240,985,175,079,139,100$239,190,373,809,905,920.00$14,998$563.56+$240985175079.12M → GFTRF
7$32,373,573,631,143,694,000$32,115,719,493,809,017,000.00$16,098$619.52+$32373573631143.68M → GFTRF
8$4,066,766,648,320,630,000,000$4,032,126,924,535,306,000,000.00$17,295$681.69+$4066766648320630.00M → GFTRF
9$477,730,483,406,513,300,000,000$473,379,043,092,810,300,000,000.00$18,599$750.82+$477730483406513344.00M → GFTRF
10$52,481,917,574,412,750,000,000,000$51,970,745,957,167,775,000,000,000.00$20,022$827.78+$52481917574412746752.00M → GFTRF

GFTRF vs JNJ: Complete Analysis 2026

GFTRF — Stock

Gold'n Futures Mineral Corp., an exploration stage company, engages in acquisition and exploration of precious and base metals properties in Canada. The company's projects include the Hercules gold project consists of 372 contiguous claim cells covering an area of 6,951 hectares located to the northeast of Thunder Bay, Ontario; and the Brady gold project located in south central Newfoundland. Its projects include the Cree Lake gold project comprises 151 single cell and 43 boundary claims covering approximately 4,074 hectares located in Swayze; and Handcamp project consists of two mineral claims covering 7,500 hectares located in central Newfoundland. The company was formerly known as European Metals Corp. and changed its name to Gold'n Futures Mineral Corp. in July 2020. Gold'n Futures Mineral Corp. is headquartered in Toronto, Canada.

Full GFTRF Calculator →

JNJ — Healthcare

Johnson & Johnson is a Dividend King with 62+ years of consecutive dividend increases. A healthcare conglomerate spanning pharmaceuticals, MedTech, and consumer health. JNJ spun off its consumer segment as Kenvue in 2023, focusing on higher-margin pharma and medical devices.

Full JNJ Calculator →
📬

Get this GFTRF vs JNJ comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

GFTRF vs SCHDGFTRF vs JEPIGFTRF vs OGFTRF vs KOGFTRF vs MAINGFTRF vs ABBVGFTRF vs MRKGFTRF vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.